Latest Headlines
-
Bruker Introduces MBT Sepsityper Kit US IVD For Rapid And Affordable Identification Of Over 400 Microorganisms From Positive Blood Cultures
1/4/2021
Bruker Corporation today announce US FDA clearance and the US launch of the MBT Sepsityper Kit US IVD for rapid microbial identification of more than 425 microorganisms from positive blood cultures on the MALDI BiotyperCASystem
-
Enzo Biochem Receives FDA Emergency Use Authorization For Testing Pooled Samples On Three Platforms Including Company’s Genflex™ Proprietary System For Detection Of Coronavirus SARS-CoV-2
1/4/2021
Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, announced today that it has received an expansion of its Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) authorizing the use of pooled samples containing up to five individual swab specimens with the Company’s AMPIPROBE® SARS-Cov-2 Test System utilizing tests on three different platforms including Enzo’s proprietary GENFLEX™ automated high-throughput platform
-
Applied DNA Partners With CLEARED4 On Pooled COVID-19 Surveillance Testing Program
12/29/2020
Applied DNA Sciences, Inc. (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that its wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC (ADCL) has entered into a reseller and sales referral partnership with CLEARED4, a field-proven, New York-based provider of return-to-work health safety solutions
-
INEX Innovate's CORO™ Real-Time RT-PCR SARS-CoV-2 Kit For The Detection Of COVID-19 Obtains Singapore's Health Sciences Authority Provisional Authorisation
12/29/2020
INEX Innovate Pte Ltd a Singapore based molecular diagnostics developer today announced that the Singapore Health Sciences Authority has issued provisional authorisation to the company's CORO™ Real-Time RT-PCR SARS-CoV-2 for the diagnosis of COVID-19
-
Instrumentation Laboratory Awarded Massachusetts Life Sciences Center Tax Incentive
12/29/2020
Instrumentation Laboratory (IL), a Werfen Company, today announced their $374,860 Tax Incentive Award from the Massachusetts Life Sciences Center (MLSC), as part of the Life Sciences Tax Incentive Program
-
Bionano Customer Praxis Genomics Accredited By College Of American Pathologists, Completing First LDT In US For Constitutional Genetic Disorders That Uses Whole Genome Analysis With Saphyr As Alternative To Chromosomal Microarray And Karyotyping
12/29/2020
Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Praxis Genomics, LLC received accreditation from the College of American Pathologists (CAP), making it the first CAP-accredited, CLIA-certified diagnostic lab in the United States to offer a laboratory developed test (LDT) based on whole genome analysis with Saphyr
-
Corning Receives Award From U.S. Department Of Defense And U.S. Department Of Health And Human Services For Products Supporting COVID-19 Testing
12/24/2020
Corning Incorporated (NYSE: GLW) today announced it has received an $15 million award from the U.S. Department of Defense (DoD), in coordination with Department of Health and Human Services (HHS), for the domestic production of robotic pipette tips used in support of diagnostic testing for COVID-19
-
OraSure’s OMNIgene®·ORAL Device Included In EUA Amendment Granted To 3B BlackBio Biotech India For SARS-CoV-2 Test
12/24/2020
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its OMNIgene®
-
Todos Medical Announces Agreement To Supply Natural Wellness Clinics With COVID-19 Testing Products To Support Initiatives In The Commonwealth Of Kentucky
12/24/2020
Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer’s disease, today announced that it has entered into a preferred vendor agreement to supply COVID-19 related testing products and services to Natural Wellness Clinics (“NWC”) for use in its efforts in testing the uninsured population in the Commonwealth of Kentucky
-
Microbix & Copan Italia Execute Strategic Agreement
12/24/2020
Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and Copan Italia S.p.A. (Copan®), the global leader in specimen collection technologies, announce their execution of a strategic agreement (Agreement) in relation to Microbix’s quality assessment products (QAPs™) and Copan’s flocked devices (FLOQ®)